Factors Affecting the Decision to Seek Health Care: The Voice of Adolescents von Ginsburg, Kenneth R, Menapace, Adrian S, Slap, Gail B

Volltext

Cellular Microparticles as Predictive Markers for Adverse Events in Patients With Implanted Ventricular Assist Devices von Walenga, J, Jeske, W, Schwartz, J, Escalante, V, Menapace, B, Coglianese, E, Kumar, E, Heroux, A, Bakhos, M

Volltext

Cyclotron production of At/Po by Bi(alpha,2n) reaction von Morzenti, S, Bonardi, M L, Groppi, F, Zona, C, Persico, E, Menapace, E, Alfassi, Z B

Volltext

Optimisation study of α-cyclotron production of At-211/Po-211g for high-LET metabolic radiotherapy purposes von Groppi, F., Bonardi, M.L., Birattari, C., Menapace, E., Abbas, K., Holzwarth, U., Alfarano, A., Morzenti, S., Zona, C., Alfassi, Z.B.

Volltext

Wet-chemistry method for the separation of no-carrier-added At/Po from Bi target irradiated by alpha-beam in cyclotron von Zona, C, Bonardi, M L, Groppi, F, Morzenti, S, Canella, L, Persico, E, Menapace, E, Alfassi, Z B, Abbas, K, Holzwarth, U, Gibson, N

Volltext

Effect of nanostructure on phase transformations during heat treatment of 2024 aluminum alloy von B. Demétrio, K., G. Nogueira, A.P., Menapace, C., Bendo, T., Molinari, A.

Volltext

Accurate determination of half-life and radionuclidic purity of reactor produced Lu (Lu) for metabolic radiotherapy von Canella, L, Bonardi, M L, Groppi, F, Persico, E, Zona, C, Menapace, E, Alfassi, Z B, Chinol, M, Papi, S, Tosi, G

Volltext

Cyclotron production of 211At/211gPo by 209Bi(α,2n) reaction von Morzenti, S., Bonardi, M. L., Groppi, F., Zona, C., Persico, E., Menapace, E., Alfassi, Z. B.

Volltext

Methamphetamine Use With Subsequent Thyrotoxicosis/Thyroid Storm, Agranulocytosis, and Modified Total Thyroidectomy: A Case Report von Viswanath, Omar, Menapace, Deanna C, Headley, Don B

Volltext

The role of mud volcanism and deep‐seated dewatering processes in the N ankai T rough accretionary prism and K umano B asin, J apan von Menapace, Walter, Völker, David, Kaul, Norbert, Tryon, Michael D., Kopf, Achim J.

Volltext

High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticles von Baiu, Dana C, Artz, Nathan S, McElreath, Meghan R, Menapace, Bryan D, Hernando, Diego, Reeder, Scott B, Grüttner, Cordula, Otto, Mario

Volltext

The National Ignition Facility 2007 laser performance status von Haynam, C A, Sacks, R A, Wegner, P J, Bowers, M W, Dixit, S N, Erbert, G V, Heestand, G M, Henesian, M A, Hermann, M R, Jancaitis, K S, Manes, K R, Marshall, C D, Mehta, N C, Menapace, J, Nostrand, M C, Orth, C D, Shaw, M J, Sutton, S B, Williams, W H, Widmayer, C C, White, R K, Yang, S T, Wonterghem, B M Van

Volltext

High-average-power femto-petawatt laser pumped by the Mercury laser facility von Bayramian, Andy, Armstrong, James, Beer, Glenn, Campbell, Rob, Chai, Bruce, Cross, Robert, Erlandson, Alvin, Fei, Yting, Freitas, Barry, Kent, Robert, Menapace, Joseph, Molander, William, Schaffers, Kathleen, Siders, Craig, Sutton, Steve, Tassano, John, Telford, Steve, Ebbers, Christopher, Caird, John, Barty, Christopher

Volltext

SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE) von Guy-Young, Kaan-Kavakli, W-Pipe, S, Alok-Srivastava, Juliana-Aragao, A-Menapace, L, Chuanwu-Zhang, Marja-Puurunen, Marek-Demissie, Gili-Kenet

Volltext

Results on accelerator production of innovative radionuclides for metabolic radiotherapy and PET and on related nuclear data von Groppi, Flavia, Bonardi, Mauro L., Menapace, Enzo, Morzenti, Sabrina, Zona, Cristiano, Canella, Lea, Alfassi, Zeev B.

Volltext

A new alpha-emitter for nuclear medicine: 230U von Alfassi, Z. B., Bonardi, M., Groppi, F., Menapace, E.

Volltext

Graph Neural Networks for Sensor Placement: A Proof of Concept towards a Digital Twin of Water Distribution Systems von Menapace, A, Zanfei, A, Herrera, M, Brentan, B

Volltext bestellen

SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE) von Guy-Young, Kaan-Kavakli, W-Pipe, S, Alok-Srivastava, Juliana-Aragao, A-Menapace, L, Chuanwu-Zhang, Marja-Puurunen, Marek-Demissie, Gili-Kenet

Volltext

Wet-chemistry method for the separation of no-carrier-added 211At/211gPo from 209Bi target irradiated by alpha-beam in cyclotron von Zona, C., Bonardi, M. L., Groppi, F., Morzenti, S., Canella, L., Persico, E., Menapace, E., Alfassi, Z. B., Abbas, K., Holzwarth, U., Gibson, N.

Volltext

A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease von Xu, Julia Z., Conrey, Anna, Frey, Ingrid, Gwaabe, Eveline, Menapace, Laurel A., Tumburu, Laxminath, Lundt, Maureen, Lequang, Timothy, Li, Quan, Glass, Kristen, Dunkelberger, Emily B., Iyer, Varsha, Mangus, Heidi, Kung, Charles, Dang, Lenny, Kosinski, Penelope A., Hawkins, Peter, Jeffries, Neal, Eaton, William A., Lay Thein, Swee

Volltext